Anastrozole Export Market Intelligence: India's 158 Suppliers Shipping to 99 Countries — TransData Nexus 2026

Q: Who are the top anastrozole exporters from India?

The top anastrozole exporters from India are: 1. INTAS PHARMACEUTICALS LIMITED — $93.8M (84.7% market share); 2. ZYDUS LIFESCIENCES LIMITED — $3.6M (3.2% market share); 3. EUGIA PHARMA SPECIALITIES LIMITED — $3.5M (3.2% market share); 4. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $3.1M (2.8% market share); 5. NATCO PHARMA LIMITED — $2.7M (2.4% market share). Together they account for 96.4% of India's total anastrozole export value.

Q: What is the total export value of anastrozole from India?

The total export value of anastrozole from India is $110.7M USD, recorded across 2,238 shipment transactions from 158 active exporters to 99 destination countries. The average shipment value is $49.5K.

Q: Which countries import anastrozole from India?

India exports anastrozole to 99 countries worldwide. The top importing countries are: UNITED STATES (92.3% share, $102.2M), BRAZIL (1.9% share, $2.1M), RUSSIA (1.7% share, $1.8M), CANADA (1.0% share, $1.2M), UNITED KINGDOM (0.7% share, $773.5K). These five markets account for 97.6% of total export value.

Q: What is the HS code for anastrozole exports from India?

The primary HS code for anastrozole exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of anastrozole exports from India?

The average unit price for anastrozole exports from India is $2.43 USD per unit, with prices ranging from $0.01 to $100.00 depending on formulation, packaging, and order volume. The total market is valued at $110.7M across 2,238 shipments.

Q: Which ports handle anastrozole exports from India?

The primary ports for anastrozole exports from India are SAHAR AIR CARGO ACC (INBOM4) (20.8% of shipments), SAHAR AIR (17.5% of shipments), DELHI AIR CARGO ACC (INDEL4) (12.5% of shipments), DELHI AIR (7.5% of shipments), MUNDRA SEA (4.0% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of anastrozole?

India is one of the world's leading exporters of anastrozole due to its large base of 158 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports anastrozole to 99 countries, demonstrating 51% global market coverage.

Q: What certifications do Indian anastrozole exporters need?

Indian anastrozole exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import anastrozole from India?

There are 387 registered buyers importing anastrozole from India, spread across 99 countries. The repeat buyer rate is 54.8%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top anastrozole supplier from India?

INTAS PHARMACEUTICALS LIMITED is the leading anastrozole exporter from India with a market share of 84.7% and total export value of $93.8M across 209 shipments. The top 5 suppliers together control 96.4% of total export value.

Suresh Sormare

Anastrozole

India Pharmaceutical Trade Intelligence

$110.7M158 Suppliers99 CountriesHS 30049099

ExportsIndia → UNITED STATES92.3%India → BRAZIL1.9%

ImportsUNITED STATES → India$10.5M ISRAEL → India$2.0M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: EVERSANA LIFE

Anastrozole Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Anastrozole to the World

Between 2022 and 2026, India exported $110.7M worth of anastrozole across 2,238 verified shipments to 99 countries — covering 51% of world markets in the Advanced Oncology segment. The largest destination is UNITED STATES (92.3%). INTAS PHARMACEUTICALS LIMITED leads with a 84.7% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Anastrozole export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Anastrozole export data snapshot — $110.7M · 158 exporters · 99 countriesTransData Nexus · Indian Customs Data

Top Anastrozole Exporters from India

158 active exporters · Ranked by export value

View all 158 →

Top Anastrozole Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	INTAS PHARMACEUTICALS LIMITED	$93.8M	209	13	84.7%
2	ZYDUS LIFESCIENCES LIMITED

Top Countries Importing Anastrozole from India

99 destination markets · Ranked by import value

All 99 countries →

Top Countries Importing Anastrozole from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$102.2M	92.3%
2	BRAZIL	$2.1M	1.9%
3	RUSSIA	$1.8M	1.7%
4	CANADA	$1.2M	1.0%
5	UNITED KINGDOM	$773.5K	0.7%
6	PHILIPPINES	$507.8K	0.5%
7	MALTA	$361.3K	0.3%
8	BELGIUM	$268.3K	0.2%
9	SRI LANKA	$198.2K	0.2%
10	GERMANY	$121.1K	0.1%

UNITED STATES is India's largest anastrozole export destination, absorbing 92.3% of total exports worth $102.2M. The top 5 importing countries — UNITED STATES, BRAZIL, RUSSIA, CANADA, UNITED KINGDOM — together account for 97.6% of India's total anastrozole export value. The remaining 94 destination countries collectively receive the other 2.4%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Anastrozole to India?

6 origin countries · Total import value: $13.0M

India imports anastrozole from 6 countries with a combined import value of $13.0M. The largest supplier is UNITED STATES ($10.5M, 16 shipments), followed by ISRAEL and CHINA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Anastrozole to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$10.5M	16	80.8%
2	ISRAEL	$2.0M	6	15.6%
3	CHINA	$373.5K	2	2.9%
4	SWITZERLAND	$89.2K	8	0.7%
5	GERMANY	$4.9K	3	0.0%
6	UNITED KINGDOM	$81	1	0.0%

UNITED STATES is the largest supplier of anastrozole to India, accounting for 80.8% of total import value. The top 5 origin countries — UNITED STATES, ISRAEL, CHINA, SWITZERLAND, GERMANY — together supply 100.0% of India's anastrozole imports. Click any country to see detailed supplier and buyer data for that import corridor.

Anastrozole — Export Intelligence Video

Visual overview of India's anastrozole import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's anastrozole pharmaceutical import and export market — $110.7M in total trade, 158 verified manufacturers, and 99 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Anastrozole

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Anastrozole has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of breast cancer in postmenopausal women. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for Anastrozole, indicating a competitive generic market. The primary regulatory pathway for Anastrozole involves the submission of an ANDA, demonstrating bioequivalence to the reference listed drug (RLD). As of December 2025, the FDA introduced updates to the Orange Book to clarify the identification of RLDs and reference standards, facilitating the ANDA submission process.

Given the substantial number of Indian exporters (158) supplying Anastrozole to the U.S., it is imperative for these entities to adhere strictly to FDA regulations. This includes compliance with Current Good Manufacturing Practices (cGMP) and ensuring that their products meet the required standards for safety, efficacy, and quality.

2EU & UK Regulatory Framework

In the European Union, Anastrozole is authorized for the treatment of hormone receptor-positive advanced breast cancer in postmenopausal women. The European Medicines Agency (EMA) has conducted periodic safety update report single assessments (PSUSAs) for Anastrozole, with the most recent assessment completed in May 2025. (ema.europa.eu) This underscores the EMA's commitment to ongoing pharmacovigilance and the maintenance of up-to-date safety information.

In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) authorized Anastrozole in November 2023 for the prevention of breast cancer in postmenopausal women at moderate or high risk. (gov.uk) This expanded indication reflects the evolving therapeutic applications of Anastrozole within the UK market.

Manufacturers exporting Anastrozole to the EU and UK must comply with the respective regulatory requirements, including obtaining marketing authorizations and adhering to Good Manufacturing Practice (GMP) standards as stipulated by the EMA and MHRA.

3WHO Essential Medicines & Global Standards

Anastrozole is included in the World Health Organization's (WHO) Model List of Essential Medicines, highlighting its significance in global health. The drug is also subject to international pharmacopoeial standards, including those of the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). Compliance with these standards ensures the quality, safety, and efficacy of Anastrozole across different markets.

4India Regulatory Classification

In India, Anastrozole is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, Anastrozole is not listed under the Drugs (Prices Control) Order (DPCO), and thus, its price is not subject to government-mandated ceilings. For export purposes, Indian manufacturers must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national export regulations.

5Patent & Exclusivity Status

The primary patents for Anastrozole have expired, leading to the availability of generic versions in various markets. This has resulted in increased competition among manufacturers and exporters, particularly from India, which has become a significant supplier of generic Anastrozole globally.

6Recent Industry Developments

In May 2025, the EMA completed a periodic safety update report single assessment (PSUSA) for Anastrozole, leading to variations in the product information to enhance safety and efficacy profiles. (ema.europa.eu)

In November 2023, the MHRA authorized Anastrozole for the prevention of breast cancer in postmenopausal women at moderate or high risk, expanding its therapeutic indications in the UK. (gov.uk)

These developments underscore the dynamic regulatory landscape surrounding Anastrozole, necessitating continuous monitoring by exporters to ensure compliance and market competitiveness.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Anastrozole

Retail & reference prices across 9 markets vs. India FOB export price of $2.43/unit

Global Price Benchmark for Anastrozole across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.22 – $1.45	USD	According to the FDA Orange Book, anastrozole is approved for use in the United States.
United Kingdom	Approximately $6.50	GBP	Anastrozole is listed in the NHS Drug Tariff, indicating its availability and pricing within the National Health Service.
Germany	Approximately $1.20	EUR	Anastrozole is approved by the European Medicines Agency (EMA) for use in Germany.
Australia	Approximately $1.10

Supply Chain Risk Assessment — Anastrozole

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Anastrozole's Active Pharmaceutical Ingredient (API) production is heavily reliant on Key Starting Materials (KSMs) such as 2,3,5-trimethoxybenzaldehyde, predominantly sourced from China. This dependency exposes the supply chain to significant risks, as disruptions in Chinese manufacturing—due to environmental regulations or geopolitical tensions—can directly impact API availability. For instance, environmental shutdowns in China's Jiangsu Province in 2022 affected approximately 30% of global intermediate production, leading to delays in API manufacturing timelines.

Furthermore, China's control over 70–80% of global KSM supply and 60–70% of intermediate supply underscores the strategic vulnerability in the pharmaceutical supply chain. This concentration means that any disruption in Chinese exports can have cascading effects on global API production, including that of Anastrozole.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters account for 96.4% of Anastrozole exports, with INTAS PHARMACEUTICALS LIMITED alone contributing 84.7% ($93.8M) of the total export value. This high supplier concentration poses a significant single-source risk; any operational or regulatory issues at INTAS could severely disrupt the global supply of Anastrozole.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme aimed at reducing import dependence on critical pharmaceutical ingredients. In October 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules like Penicillin G and Clavulanic Acid, marking a step towards enhancing domestic production capabilities.

Access Complete Anastrozole Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 2,238 transactions across 99 markets.

Request Demo View Pricing

Frequently Asked Questions — Anastrozole Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top anastrozole exporters from India?

The leading anastrozole exporters from India are INTAS PHARMACEUTICALS LIMITED, ZYDUS LIFESCIENCES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, and 9 others. INTAS PHARMACEUTICALS LIMITED leads with 84.7% market share ($93.8M). The top 5 suppliers together control 96.4% of total export value.

What is the total export value of anastrozole from India?

The total export value of anastrozole from India is $110.7M, recorded across 2,238 shipments from 158 active exporters to 99 countries. The average shipment value is $49.5K.

Which countries import anastrozole from India?

India exports anastrozole to 99 countries. The top importing countries are UNITED STATES (92.3%), BRAZIL (1.9%), RUSSIA (1.7%), CANADA (1.0%), UNITED KINGDOM (0.7%), which together account for 97.6% of total export value.

What is the HS code for anastrozole exports from India?

The primary HS code for anastrozole exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Anastrozole

Anastrozole

Top Anastrozole Exporters from India

Top Countries Importing Anastrozole from India

Who Supplies Anastrozole to India?

Quick Facts

Related Advanced Oncology

Related Analysis

Need Details?

Anastrozole — Export Intelligence Video

Regulatory Landscape — Anastrozole

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Anastrozole

Supply Chain Risk Assessment — Anastrozole

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Anastrozole Trade Intelligence

Frequently Asked Questions — Anastrozole Exports from India

Who are the top anastrozole exporters from India?

What is the total export value of anastrozole from India?

Which countries import anastrozole from India?

What is the HS code for anastrozole exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of anastrozole exports from India?

Which ports handle anastrozole exports from India?

Why is India a leading exporter of anastrozole?

What certifications do Indian anastrozole exporters need?

How many buyers import anastrozole from India?

What is the market share of the top anastrozole exporter from India?

Analysis Methodology